clarinex d 24 hour Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clarinex D 24 Hour, and what generic alternatives are available?
Clarinex D 24 Hour is a drug marketed by Organon and is included in one NDA.
The generic ingredient in CLARINEX D 24 HOUR is desloratadine; pseudoephedrine sulfate. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for clarinex d 24 hour?
- What are the global sales for clarinex d 24 hour?
- What is Average Wholesale Price for clarinex d 24 hour?
Summary for clarinex d 24 hour
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 19 |
Patent Applications: | 6 |
DailyMed Link: | clarinex d 24 hour at DailyMed |
Recent Clinical Trials for clarinex d 24 hour
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
J. Uriach and Company | Phase 1 |
UCB Pharma | Phase 4 |
Derm Research, PLLC | Phase 4 |
US Patents and Regulatory Information for clarinex d 24 hour
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | CLARINEX D 24 HOUR | desloratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 021605-001 | Mar 3, 2005 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for clarinex d 24 hour
International Patents for clarinex d 24 hour
See the table below for patents covering clarinex d 24 hour around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 140450 | ⤷ Subscribe | |
Hungary | 0004988 | ⤷ Subscribe | |
Slovenia | 1110543 | ⤷ Subscribe | |
Philippines | 23821 | AN IMPROVED PROCESS FOR THE PREPARATION OF PIPERIDYLIDENE DIHYDROBENZO(A,D)CYCLOHEPTENES AND AZADERIVATIVES THEREOF | ⤷ Subscribe |
Portugal | 1112738 | ⤷ Subscribe | |
Hong Kong | 1090840 | ⤷ Subscribe | |
New Zealand | 509028 | Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for clarinex d 24 hour
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1110543 | C 2008 001 | Romania | ⤷ Subscribe | PRODUCT NAME: COMBINATIE DE DESLORATADINA, OPTIONAL SUB FORMA DE SAREACCEPTABILA FARMACEUTIC SI PSEUDOEFEDRINA OPTIONAL SUB FORMA DE SARE SAU ESTER ACCEPTABILEFARMACEUTIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/07/399/001, RO EU/1/07/399/002, RO EU/1/07/399/003, RO EU/1/07/399/004, RO EU/1/07/399/005, RO EU/1/07/399/006; DATE OF NATIONAL AUTHORISATION: 20070730; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/07/399/001, EU/1/07/399/002, EU/1/07/399/003, EU/1/07/399/004, EU/1/07/399/005, EU/1/07/399/006; DATE OF FIRST AUTHORISATION IN EEA: 20070730 |
1110543 | 122008000001 | Germany | ⤷ Subscribe | PRODUCT NAME: DESLORATADIN MIT PSEUDOEPHEDRIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ VON PSEUDOEPHEDRIN; REGISTRATION NO/DATE: EU/1/07/399/001-006 20070730 |
1110543 | SPC/GB08/005 | United Kingdom | ⤷ Subscribe | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
1110543 | CA 2008 00010 | Denmark | ⤷ Subscribe | PRODUCT NAME: KOMBINATION OMFATTENDE DESLORATADIN OG PSEUDOEPHEDRIN, EVENTUELT I FORM AF ET FYSIOLOGISK ACCEPTABELT SALT IFOELGE NEDENSTAENDE GRUNDPATENT, HERUNDER PSEUDOEPHEDRIN SOM SULFAT |
1110543 | 1/2008 | Austria | ⤷ Subscribe | PRODUCT NAME: DESLORATADIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, KOMBINIERT MIT PSEUDOEPHEDRIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES ODER ESTERS; REGISTRATION NO/DATE: EU/1/07/399/001-006 20070730 |
1110543 | SPC063/2007 | Ireland | ⤷ Subscribe | SPC063/2007: 20081105, EXPIRES: 20220729 |
1110543 | 91403 | Luxembourg | ⤷ Subscribe | 91403, EXPIRES: 20220730 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Clarinex d 24 hour Market Analysis and Financial Projection Experimental
More… ↓